Galectin Therapeutic (GALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | GALT | ATNM | ZVRA | ||
Company | Galectin Therapeutic | Actinium Pharmaceuticals Inc | Zevra Therapeutics Inc | ||
Price Information | |||||
Exchange | NASDAQ | NYSE Arca | NASDAQ | ||
Open | 3.36 | 6.93 | 4.58 | ||
High | 3.51 | 7.32 | 4.60 | ||
Low | 3.27 | 6.88 | 4.49 | ||
Last | 3.29 | 7.06 | 4.56 | ||
Change | -0.09 | +0.10 | -0.02 | ||
% Change | -2.66% | +1.44% | -0.44% | ||
Volume | 162,400 | 153,400 | 159,000 | ||
20-Day Average Volume | 302,915 | 366,825 | 259,815 | ||
Previous Close | 3.38 | 6.96 | 4.58 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 3.31 | 8.19 | 4.90 | ||
20-Day Raw Stochastic | 51.28% | 14.94% | 8.67% | ||
20-Day Relative Strength | 57.72% | 44.79% | 34.51% | ||
Weighted Alpha | +55.64 | -24.70 | -30.95 | ||
Today's Opinion | 80% Buy | 56% Buy | 40% Sell | ||
Previous Opinion | 96% Buy | 56% Buy | 40% Sell | ||
Last Month's Opinion | 96% Buy | 88% Buy | 56% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | -2.66% since 04/17/24 | -2.62% since 04/17/24 | -1.72% since 04/17/24 | ||
Low | 2.88 on 04/22/24 | 6.60 on 04/19/24 | 4.39 on 04/19/24 | ||
High | 3.55 on 04/23/24 | 7.51 on 04/18/24 | 4.68 on 04/23/24 | ||
1-Month | |||||
%Chg | +34.84% since 03/22/24 | -23.26% since 03/22/24 | -20.83% since 03/22/24 | ||
Low | 2.26 on 04/01/24 | 6.60 on 04/19/24 | 4.39 on 04/19/24 | ||
High | 4.27 on 04/12/24 | 9.68 on 04/08/24 | 6.35 on 03/28/24 | ||
3-Month | |||||
%Chg | +91.28% since 01/24/24 | +38.70% since 01/24/24 | -20.56% since 01/24/24 | ||
Low | 1.59 on 02/07/24 | 5.00 on 01/25/24 | 4.39 on 04/19/24 | ||
High | 4.27 on 04/12/24 | 9.86 on 03/22/24 | 7.28 on 02/20/24 | ||
6-Month | |||||
%Chg | +58.94% since 10/24/23 | +30.74% since 10/24/23 | +4.35% since 10/24/23 | ||
Low | 1.55 on 12/29/23 | 4.00 on 11/28/23 | 3.89 on 11/13/23 | ||
High | 4.27 on 04/12/24 | 9.86 on 03/22/24 | 7.28 on 02/20/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 203,664 | 207,536 | 198,023 | ||
Shares Outstanding, K | 61,904 | 29,396 | 43,426 | ||
Annual Sales | 0 | 80,000 | 27,460,000 | ||
Annual Net Income | -41,070,000 | -48,820,000 | -46,050,000 | ||
Last Quarter Sales | 0 | 80,000 | 13,220,000 | ||
Last Quarter Net Income | -10,000,000 | -9,320,000 | -15,150,000 | ||
60-Month Beta | 0.84 | 0.01 | 1.81 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.16 on 03/29/24 | -0.33 on 03/29/24 | -0.40 on 03/28/24 | ||
Latest Earnings Date | 05/20/24 | 05/20/24 | 05/20/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |